Lixisenatide
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 687 publications
Influence of GLP-1 Receptor Agonists on Surgical and Nonsurgical Treatment of Ankle Osteoarthritis.
Journal: Foot & ankle specialist
Published: August 18, 2026
Glucagon-like Peptide-1 Receptor Agonist-Associated Injection Site and Dermatologic Reactions.
Journal: Clinics in dermatology
Published: August 14, 2026
The role of GLP-1 and GIP receptor agonists in the treatment of diabetes and obesity.
Journal: Pharmacological research
Published: July 27, 2026
Postmarketing Safety Signals and Medication-Use Risks of GLP-1-Based Therapies in Diabetes and Obesity: A Multi-Source Pharmacovigilance and Regulatory Evidence-Mapping Study.
Journal: Diabetes, obesity & metabolism
Published: July 14, 2026
Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity: A Living Systematic Review and Network Meta-analysis for the American College of Physicians.
Journal: Annals of internal medicine
Published: June 15, 2026
iGlarlixi for the simplification of more complex insulin regimens in type 2 diabetes patients with good glycaemic control.
Journal: Frontiers in endocrinology
Published: June 11, 2026
GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease.
Journal: Frontiers in neuroscience
Published: June 11, 2026
Use of fixed-ratio combination of basal insulin and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Asians with type 2 diabetes.
Journal: Primary care diabetes
Published: May 29, 2026
GLPs Significantly Decrease the Risk of Postoperative Surgical Complications: A TriNetX Retrospective Cohort Study.
Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Published: May 29, 2026
Beyond Glycemic Control: Real-World 12-Month Effects of Insulin Glargine/Lixisenatide on Weight, Endogenous Insulin Secretion, and Albuminuria.
Journal: Journal of clinical medicine
Published: May 22, 2026
GLP-1 Receptor Agonist Therapy in Children and Adolescents with Obesity: A Network Meta-Analysis of Differential Cardiometabolic Efficacy and Safety Profiles.
Journal: Pharmacological research
Published: May 10, 2026
Efficacy and Safety of iGlarLixi Versus IDegAsp by Baseline Age, Disease Duration and HbA1c in Chinese People With Type 2 Diabetes: Post Hoc Analyses of the Soli-D Study.
Journal: Diabetes, obesity & metabolism
Published: May 06, 2026
Last Updated: 09/26/2026